These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22726273)
1. Peroxisome proliferator-activated receptor gamma modulation and lipogenic response in adipocytes of small-for-gestational age offspring. Yee JK; Lee WN; Ross MG; Lane RH; Han G; Vega J; Desai M Nutr Metab (Lond); 2012 Jun; 9(1):62. PubMed ID: 22726273 [TBL] [Abstract][Full Text] [Related]
2. Organ-specific alterations in fatty acid de novo synthesis and desaturation in a rat model of programmed obesity. Yee JK; Lee WN; Han G; Ross MG; Desai M Lipids Health Dis; 2011 May; 10():72. PubMed ID: 21569358 [TBL] [Abstract][Full Text] [Related]
3. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation. Witte N; Muenzner M; Rietscher J; Knauer M; Heidenreich S; Nuotio-Antar AM; Graef FA; Fedders R; Tolkachov A; Goehring I; Schupp M Endocrinology; 2015 Nov; 156(11):4008-19. PubMed ID: 26181104 [TBL] [Abstract][Full Text] [Related]
5. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920 [TBL] [Abstract][Full Text] [Related]
6. Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes. Shinohara S; Fujimori K Biochem Biophys Res Commun; 2020 Jun; 527(1):49-55. PubMed ID: 32446390 [TBL] [Abstract][Full Text] [Related]
7. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881 [TBL] [Abstract][Full Text] [Related]
8. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. Takasawa K; Kubota N; Terauchi Y; Kadowaki T Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083 [TBL] [Abstract][Full Text] [Related]
9. Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Ahmed S; Atlas E Int J Obes (Lond); 2016 Oct; 40(10):1566-1573. PubMed ID: 27273607 [TBL] [Abstract][Full Text] [Related]
11. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro. Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399 [TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats. Teruel T; Hernandez R; Rial E; Martin-Hidalgo A; Lorenzo M Diabetologia; 2005 Jun; 48(6):1180-8. PubMed ID: 15887043 [TBL] [Abstract][Full Text] [Related]
13. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis. Hamza MS; Pott S; Vega VB; Thomsen JS; Kandhadayar GS; Ng PW; Chiu KP; Pettersson S; Wei CL; Ruan Y; Liu ET PLoS One; 2009; 4(3):e4907. PubMed ID: 19300518 [TBL] [Abstract][Full Text] [Related]
14. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260 [TBL] [Abstract][Full Text] [Related]
15. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells. Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620 [TBL] [Abstract][Full Text] [Related]
17. Gangjihwan, a polyherbal composition, inhibits fat accumulation through the modulation of lipogenic transcription factors SREBP1C, PPARγ and C/EBPα. Jang J; Jung Y; Chae S; Cho SH; Yoon M; Yang H; Shin SS; Yoon Y J Ethnopharmacol; 2018 Jan; 210():10-22. PubMed ID: 28842339 [TBL] [Abstract][Full Text] [Related]
18. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Seo JB; Moon HM; Kim WS; Lee YS; Jeong HW; Yoo EJ; Ham J; Kang H; Park MG; Steffensen KR; Stulnig TM; Gustafsson JA; Park SD; Kim JB Mol Cell Biol; 2004 Apr; 24(8):3430-44. PubMed ID: 15060163 [TBL] [Abstract][Full Text] [Related]